Tachykinins in the gut .1. Expression, release and motor function

被引:284
作者
Holzer, P
HolzerPetsche, U
机构
[1] Dept. of Exp. and Clin. Pharmacology, University of Graz, Universitätsplatz 4
关键词
substance P; neurokinin A; enteric nervous system; intestinal motility; peristalsis; intestinal motor disorders;
D O I
10.1016/S0163-7258(96)00195-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The preprotachykinin-A gene-derived peptides substance P and neurokinin (NK) A are expressed in distinct neural pathways of the mammalian gut. When released from intrinsic enteric or extrinsic primary afferent neurons, tachykinins have the potential to influence both nerve and muscle by way of interaction with three different types of tachykinin receptor, termed NK1, NK2 and NK3 receptors. Most prominent among the effects of tachykinins is their excitatory action on gastrointestinal motor activity, which is seen in virtually all regions and layers of the mammalian gut. This action depends not only on a direct activation of the muscle through NK1 and/or NK2 receptors, but also on stimulation of excitatory enteric motor pathways through NK3 and/or NK1 receptors. In addition, tachykinins can inhibit motor activity by stimulating either inhibitory neuronal pathways or interrupting excitatory relays. A synopsis of the available data indicates that endogenous substance P and NKA interact with other enteric transmitters in the physiological control of gastrointestinal motor activity. Derangement of the regulatory roles of tachykinins may be a factor in the gastrointestinal dysmotility associated with infection, inflammation, stress and pain. In a therapeutic perspective, it would seem conceivable, therefore, that tachykinin agonists and antagonists are adjuncts to the treatment of motor disorders that involve pathological disturbances of the gastrointestinal tachykinin system. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:173 / 217
页数:45
相关论文
共 501 条
[1]   REGULATORY PEPTIDES IN LOWER ESOPHAGEAL SPHINCTER OF PIG AND MAN [J].
AGGESTRUP, S ;
UDDMAN, R ;
JENSEN, SL ;
HAKANSON, R ;
SUNDLER, F ;
DEMUCKADELL, OS ;
EMSON, P .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (12) :1370-1375
[2]   CARCINOID-TUMOR CELLS IN LONG-TERM CULTURE - RELEASE OF SEROTONIN BUT NOT OF TACHYKININS ON STIMULATION WITH ADRENOCEPTOR AGONISTS [J].
AHLMAN, H ;
AHLUND, L ;
NILSSON, O ;
SKOLNIK, G ;
THEODORSSON, E ;
DAHLSTROM, A .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :506-510
[3]   THE ACTIONS OF NEUROKININS AND SUBSTANCE-P IN CANINE PYLORUS, ANTRUM AND DUODENUM [J].
ALLESCHER, HD ;
KOSTOLANSKA, F ;
TOUGAS, G ;
FOX, JET ;
REGOLI, D ;
DRAPEAU, G ;
DANIEL, EE .
PEPTIDES, 1989, 10 (03) :671-679
[4]   INNERVATION OF THE MUSCULARIS MUCOSAE OF CANINE PROXIMAL COLON [J].
ANGEL, F ;
GO, VLW ;
SZURSZEWSKI, JH .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 357 (DEC) :93-108
[5]   COMPARISON OF NK-2 SELECTIVE PEPTIDE AND NONPEPTIDE ANTAGONISTS IN RAT DISTAL COLON MUSCULARIS MUCOSAE [J].
ASTOLFI, M ;
MANZINI, S ;
MAGGI, CA ;
GIACHETTI, A .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1993, 13 (06) :381-386
[6]   BRAIN-GUT INTERACTIONS - BRAIN-STEM NEURONAL RESPONSE TO LOCAL GASTRIC EFFECTS OF SUBSTANCE-P [J].
BARBER, WD ;
BURKS, TF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (03) :G369-G377
[7]  
BARKER LA, 1982, J PHARMACOL EXP THER, V221, P69
[8]  
BARON SA, 1983, J PHARMACOL EXP THER, V227, P365
[9]   NONPEPTIDE ANTAGONISTS, CP-96,345 AND RP-67580, DISTINGUISH SPECIES VARIANTS IN TACHYKININ NK(1)-RECEPTORS [J].
BARR, AJ ;
WATSON, SP .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) :223-227
[10]   THEOPHYLLINE-SENSITIVE MODULATION OF NON-CHOLINERGIC EXCITATORY NEUROTRANSMISSION IN THE GUINEA-PIG ILEUM [J].
BARTHO, L ;
PETHO, G ;
RONAI, Z .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (02) :315-317